Clinical Trial Update: Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for flortaucipir PET imaging in preclinical, prodromal, and dementia stages of Alzheimer’s disease; results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Flortaucipir (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Status: COMPLETED | Results posted: 2020-09-25